Novanta (NOVT) vs USBC (USBC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Novanta (NOVT) has outperformed USBC (USBC) over the past year, gaining 42.3% versus a loss of 50.9%. Over five years, NOVT leads with a -11.1% price change compared with -99.5% for USBC. Novanta is the larger company by market cap ($5.43 billion vs $209.6 million), about 25.9 times the size.
On valuation, USBC trades at a lower trailing P/E (0.2x vs 90.9x for Novanta).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NOVT | USBC |
|---|---|---|
| Share price | $143.64 | $0.54 |
| Market cap | $5.43B | $209.60M |
| 1-day change | -3.66% | -1.73% |
| YTD return | +20.72% | -14.29% |
| 1-year return | +42.26% | -50.91% |
| 5-year return | -11.06% | -99.46% |
| P/E ratio (TTM) | 90.91 | 0.23 |
| Forward P/E | 32.89 | — |
| EPS (TTM) | $1.58 | $2.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $980.60M | — |
| Revenue growth (YoY) | +3.30% | — |
| Net income (latest FY) | $53.83M | — |
| Gross margin | 44.39% | — |
| Operating margin | 9.59% | — |
| Net margin | 5.49% | — |
| 52-week high | $176.38 | $1.29 |
| 52-week low | $98.27 | $0.29 |
| Distance from 52-week high | -18.56% | -58.14% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +35.41% | — |
| Average volume | 389.49K | 309.55K |
| Shares outstanding | 37.82M | 388.14M |
| Employees | 3,000 | 16 |
| Sector | Miscellaneous | Finance |
| Industry | Industrial Machinery/Components | Finance: Consumer Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Novanta is about 25.9 times larger than USBC by market value ($5.43B vs $209.60M).
- NOVT has outperformed USBC by 93.2 percentage points over the past year.
- Novanta trades at a higher earnings multiple (90.9x vs 0.2x trailing P/E).
- The two companies sit in different sectors: Novanta in Miscellaneous and USBC in Finance.
About Novanta
NOVT stock →Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments.
Miscellaneous · Industrial Machinery/Components · 3,000 employees
About USBC
USBC stock →USBC, Inc., together with its subsidiaries, operates in digital financial technologies business in United States. The company develops transformative financial services, including digital assets, banking solutions, and non-invasive health monitoring research.
Finance · Finance: Consumer Services · 16 employees
NOVT vs USBC FAQ
Which is bigger, Novanta or USBC?
Novanta (NOVT) is larger, with a market capitalization of $5.43B compared with $209.60M for USBC (USBC).
Which stock has performed better over the past year, NOVT or USBC?
NOVT returned +42.26% over the past 12 months, compared with -50.91% for USBC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NOVT or USBC?
USBC has the lower trailing P/E at 0.2, versus 90.9 for NOVT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Novanta and USBC in the same industry?
No. Novanta is in the Miscellaneous sector, while USBC is in Finance.